Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE – Research Report), Nanobiotix (NBTX – Research ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

Representative Rob Bresnahan, Jr. of Pennsylvania recently made headlines—not for legislation, but for investing between ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 10.67%, which has investors questioning if this is right time ...

While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...

When a commercial aircraft encounters turbulence, a flight attendant will tell all passengers to return to their seats and buckle their seat belts. Some investors think a similar approach is ...